Supemtek solution for injection in pre-filled syringe
Quadrivalent Influenza Vaccine (recombinant, prepared in cell culture)

OVERVIEW

Therapeutic indication

Supemtek is indicated for active immunization for the prevention of influenza disease in adults.

Supemtek should be used in accordance with official recommendations.

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

Supemtek Prescribing information

View the Supemtek SmPC

Adverse events should be reported.

Reporting forms and information can be found at yellowcard.mhra.gov.uk

or search for MHRA Yellow Card in the Google Play or Apple App Store.

Adverse events should also be reported to Sanofi on 0800 090 2314.

Alternatively, send via email to UK-drugsafety@sanofi.com.

Supemtek SmPC

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

Supemtek Prescribing information

View the Supemtek SmPC

Flu Patient Materials Ordering Online – Giving You Access to A Range Of Support Materials

Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.

• Simply visit https://sanofi.medisa.com

• Select the user group which best describes your role in your organisation

• Narrow your search by selecting the appropriate disease area

• Select which materials you would like to receive and how many

• Log-in or register to create an account

• Confirm your order

VISIT MEDISA

 

MAT-GB-2004300 (v1.0) | March 2021